An Expanded Access Program of Tarceva (Erlotinib) in Patients With Advanced Stage IIIB/IV Non-Small Cell Lung Cancer
Latest Information Update: 31 Dec 2021
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms TRUST
- Sponsors Roche
- 07 Jan 2016 Results of pooled analysis of seven studies published in the Journal of Thoracic Oncology
- 05 Dec 2011 Additional location (Hong Kong) added as reported by ClinicalTrials.gov.
- 19 Sep 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.